Key result
National cohort evaluates real-world genetic testing practices across 1.7 million cardiomyopathy patients.
Cohort study reveals real-world genetic testing adoption in cardiomyopathy, highlighting practice patterns across national healthcare systems.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Bui et al. (2026) studied this question. Genetic testing practices in cardiomyopathy were evaluated in a national cohort of 1.7 million patients, but specific clinical findings are not provided in this preliminary abstract.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: